The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
We focus on a number of topic areas identified by state health policy leaders as important to population health.
The Center for Evidence-based Policy at Oregon Health & Science University is a national leader in evidence-based decision making and policy design.
Keep up with news and updates from the Milbank Memorial Fund. Get the latest from thought leaders, including Christopher F. Koller, president of the Fund.
We publish The Milbank Quarterly, as well as reports and issues briefs on topics important to population health.
June 2005 (Volume 83)
June 2005 | Jill R. Horwitz, Marion R. Fremont-Smith
New York’s Empire Blue Cross and Blue Shield conversion from nonprofit to for-profit form has considerable legal significance. Three aspects of the conversion make the case unique: the role of the state legislature in directing the disposition of the conversion assets, the fact that it made itself the primary beneficiary of those assets, and the actions of the state attorney general defending the state rather than the public interest in the charitable assets. Drawing on several centuries of common law rejecting the legislative power to direct the disposition of charitable funds, this article argues that the legislature lacked power to control the conversion and direct the disposition of its proceeds and that its actions not only undermined the nonprofit form but also raised constitutional concerns.
Author(s): Jill R. Horwitz; Marion R. Fremont-Smith
Keywords: organizations; nonprofit; Blue-Cross plans; legal aspects; for-profit conversions
Read on Wiley Online Library
Read on JSTOR
Volume 83, Issue 2 (pages 225–246)
Published in 2005
The Politics of Racial Disparities: Desegregating the Hospitals in Jackson, Mississippi
One of These Things Is Not Like the Others: The Idea of Precedence in Health Technology Assessment and Coverage Decisions